Patient's question:
How to treat pathological jaundice in infants caused by cytomegalovirus infection, and what are the effective remedies? Those who understand are welcome to guide me - Thank you. First follow-up question: My little girl is still young. How should she be treated with the least harm?Doctor's answer:
Pathological jaundice often exhibits the following characteristics:① Jaundice appears within 24 hours after birth;
② Severe jaundice, with serum bilirubin > 205.2~256.5 μmol/L, or a daily increase of more than 85 μmol/L (5 mg/dL);
③ Prolonged duration of jaundice (full-term infants > 2 weeks, preterm infants > 4 weeks);
④ Relapse of jaundice after resolution;
⑤ Serum conjugated bilirubin > 26 μmol/L (1.5 mg/dL).
Active investigation of the underlying cause is essential for pathological jaundice. The main causes of pathological jaundice include:
1. Infectious causes
(1) Neonatal hepatitis: Most cases are caused by viral infections in utero, with cytomegalovirus being the most common. Others include hepatitis B, rubella, herpes simplex, Coxsackie virus, EB virus, listeria, syphilis, and toxoplasmosis. Infection can be transmitted to the fetus via the placenta or acquired during delivery through the birth canal. Jaundice typically appears 1–3 weeks or later after birth. In severe cases, the stool may be pale or grayish-white, and urine may appear dark yellow. The infant may exhibit poor appetite, vomiting, and mild to moderate hepatomegaly.
(2) Neonatal sepsis.
2. Non-infectious causes
(1) Neonatal hemolytic disease.
(2) Biliary atresia. This condition is now confirmed to be primarily caused by in utero viral infections leading to postnatal progressive cholangitis, biliary fibrosis, and biliary atresia. If the bile duct wall is weak, it may develop into a choledochal cyst. Jaundice typically appears 2 weeks after birth and progressively worsens. The stool color changes from pale yellow to white, the liver progressively enlarges with a hard and smooth edge, and liver function abnormalities are mainly characterized by increased conjugated bilirubin. It may gradually progress to cirrhosis within 3 months.
(3) Breast milk jaundice: Approximately 1% of breastfed infants develop breast milk jaundice, characterized by non-hemolytic unconjugated bilirubin elevation. It often overlaps with physiological jaundice and persists without resolution. Serum bilirubin may reach as high as 342 μmol/L (20 mg/dL), but the infant is generally in good condition. Jaundice typically subsides within 4–12 weeks, and no other identifiable cause of jaundice is present. Diagnosis is confirmed if jaundice decreases by 3 days after stopping breastfeeding. Current theories suggest that this is due to excessively high β-glucuronidase activity in the breast milk, which increases the reabsorption of bilirubin in the intestine, leading to jaundice. Some researchers propose that it is caused by a lack of bacteria in the gut that can convert bilirubin into urobilinogen and stercobilin.
(4) Hereditary diseases: G6PD (glucose-6-phosphate dehydrogenase) deficiency is common in southern China and is associated with a higher incidence of kernicterus. Other conditions include pyruvate kinase deficiency, spherocytosis, galactosemia, α1-antitrypsin deficiency, and cystic fibrosis.
(5) Drug-induced jaundice, such as that caused by drugs like K3, K4, and neomycin.